Your Brief
AI-nativeSave now. We'll handle it.
yourbrief.app Chrome Web Store Google PlayEntertainment & Media / News & Media
- Monthly visits
- <5K
- Oct 2026
- Public revenue
- Undisclosed
- No public revenue evidence yet
- Entry price
- Unknown
- No monthly subscription pricing
- Launched
- 9mo ago
- 2026-02-12 · Est.
Traffic
Marketing moves
Launches, search & content, referrals, promotionsStore data
Save articles and content to your daily brief
- Rating
- Rating not syncedRating count not synced
- New ratings last mo
- —
- Price & IAP
- FreeIAP data not synced
- Users
- 3Public store figure
Save articles, videos, and web content to your daily AI-powered audio brief. Turn your reading queue into a focused summary you can listen to on the go.
- Rating
- Rating not syncedRating count not synced
- New ratings last mo
- —
- Price & IAP
- FreeIAP data not synced
- Current version
- —Store metadata
Store assets, rating histograms, install tiers, and screenshots are synced from Apple App Store, Google Play, and Chrome Web Store.
Traffic sources
Traffic breakdown
Channels
- Direct39%
- Organic Search29%
- Referrals13%
- Social7%
- Other13%
Countries
- India100%
Search
Domain authority —Domain registered 2026-01-12
No search keyword data for this website yet.
Traffic data: Vaneform
Pricing
Pricing page not identified yet, or no public pricing listed.
Pages & changes
Key pages
Weekly snapshotsChanges
No pricing, plan, or positioning changes detected since tracking started.
Questions & evidence
- How much website traffic does Your Brief get?
- Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
- What is Your Brief and what platforms does it support?
- Your Brief is catalogued under News & Media: Save now. We'll handle it.. Supported platforms: Mobile App, Browser Extension.
Related products in this category
These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.